Switch theme
Sign up to access all valuation multiples
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
1996
11.3K+
LTM Revenue $1.7B
Last FY EBITDA -$78.8M
$514M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nu Skin has a last 12-month revenue (LTM) of $1.7B and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Nu Skin achieved revenue of $1.7B and an EBITDA of -$78.8M.
Nu Skin expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nu Skin valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| Gross Profit | $1.7B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 68% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$78.8M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -5% | XXX | XXX | XXX |
| EBIT | n/a | XXX | $50.8M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | 3% | XXX | XXX | XXX |
| Net Profit | -$147M | XXX | -$147M | XXX | XXX | XXX |
| Net Margin | -8% | XXX | -8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $207M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Nu Skin's stock price is $9.
Nu Skin has current market cap of $426M, and EV of $514M.
See Nu Skin trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $514M | $426M | XXX | XXX | XXX | XXX | $0.84 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Nu Skin has market cap of $426M and EV of $514M.
Nu Skin's trades at 0.3x EV/Revenue multiple, and -6.5x EV/EBITDA.
Equity research analysts estimate Nu Skin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nu Skin has a P/E ratio of -2.9x.
See valuation multiples for Nu Skin and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $426M | XXX | $426M | XXX | XXX | XXX |
| EV (current) | $514M | XXX | $514M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -6.5x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 10.1x | XXX | XXX | XXX |
| EV/Gross Profit | 0.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | -2.9x | XXX | -2.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 7.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNu Skin's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Nu Skin's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nu Skin's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nu Skin and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -5% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 38% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 65% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nu Skin acquired XXX companies to date.
Last acquisition by Nu Skin was XXXXXXXX, XXXXX XXXXX XXXXXX . Nu Skin acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Nu Skin founded? | Nu Skin was founded in 1996. |
| Where is Nu Skin headquartered? | Nu Skin is headquartered in United States of America. |
| How many employees does Nu Skin have? | As of today, Nu Skin has 11.3K+ employees. |
| Who is the CEO of Nu Skin? | Nu Skin's CEO is Mr. Ryan S. Napierski. |
| Is Nu Skin publicy listed? | Yes, Nu Skin is a public company listed on NYS. |
| What is the stock symbol of Nu Skin? | Nu Skin trades under NUS ticker. |
| When did Nu Skin go public? | Nu Skin went public in 1996. |
| Who are competitors of Nu Skin? | Similar companies to Nu Skin include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Nu Skin? | Nu Skin's current market cap is $426M |
| What is the current revenue of Nu Skin? | Nu Skin's last 12 months revenue is $1.7B. |
| What is the current EV/Revenue multiple of Nu Skin? | Current revenue multiple of Nu Skin is 0.3x. |
| Is Nu Skin profitable? | Yes, Nu Skin is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
